CAS: 76470-66-1; Loracarbef

该化合物是属于乙型照光抗生素类的合成抗生素,特别是卡巴培宁,主要用于治疗细菌感染,特别是克抗体和某些克抗菌细菌的感染; Loracarbef 禁止细菌细胞墙合成,导致细胞分解和死亡; 化合物的特点是稳定,防止某些乙型照光酶,这些酶是细菌产生的,可以使许多其他抗生素停止活动的酶; Loracarbef 通常通过口服,以其有利的药用植物基因特性为名,包括良好的吸收和人体组织分布; 其副作用的发生率相对较低,因此适合各种感染; 但是,如同所有抗生素一样,其使用应该以易感染性模式为指导,以避免抗药性的发展; 与任何药物一样,在开Loracarbef 之前,必须考虑与其他药物的潜在相互作用以及病人的总体健康状况.

结构式图片

MSDS等安全信息

    上下游产品

    CAS号24461-61-8 methyl (R)-amin... | CAS号76497-76-2 3-chloro-1-carb... | CAS号124831-36-3 N-((2R,3S)-2-(2... | CAS号119892-46-5 p-nitrobenzyl 7... | CAS号124831-37-4 cis-4-oxo-3-[(p... | CAS号119892-48-7 cis-α-diazo-β,4... | CAS号124831-38-5 cis-β,4-dioxo-3... | CAS号123932-46-7 carbacephalospo... | CAS号40778-79-8 3-[((R)-carboxy...

    合成工艺路线路线简述

      📜Mono N,N-Dmac Solvate Of Loracarbef置于盐酸,甲烷,氨体系中,用 水 作为反应溶剂,化学反应 1.67H,反应生成 氯碳头孢
      参考文献: Monohydrate Solvates Of Loracarbef[fr] Solvates De Monohydrate De Loracarbef
      标题: Monohydrate Solvates Of Loracarbef[fr] Solvates De Monohydrate De Loracarbef
      摘要:本发明涉及洛拉卡贝芬的单水合物溶剂物.本发明还涉及制备洛拉卡贝芬溶剂物,从所述溶剂物中制备洛拉卡贝芬结晶单水合物和包括所述结晶单水合物的制药组合物的过程.

      海关参考信息

      专利信息


      专利号:US-9353057-B2
      优先权日:2003-12-30
      标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
      发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
      权利人:XENOPORT INC
      摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

      专利号:US-10925977-B2
      优先权日:2006-10-05
      标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
      发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
      权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
      摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

      专利号:US-2024197774-A1
      优先权日:2021-04-16
      标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
      发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
      权利人:UNIV TEXAS
      摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.

      专利号:US-2005186197-A1
      优先权日:2002-08-29
      标 题:Peptide inhibitors of beta lactamases
      发明人:PALZKILL TIMOTHY; HUANG WANZHI
      摘要:Peptide inhibitors of β-lactamases have been identified by the synthesis of peptide arrays using synthesis SPOT technology. These peptide inhibitors of β-lactamase have activity against a broad spectrum of β-lactamases and are useful in a variety of applications.

      专利号:US-10899773-B2
      优先权日:2014-12-19
      标 题 :Total synthesis of trioxacarcin DC-45-A2 and preparation of trioxacarcin analogs
      发明人:NICOLAOU KYRIACOS C; CAI QUAN
      权利人:UNIV RICE WILLIAM M
      摘要:In one aspect, the present invention provides novel derivatives of trioxacarin analogs of the formula (I) wherein the variables are as defined herein. The application also provides compositions, methods of treatment, and methods of synthesis thereof.

      专利号:US-8557979-B2
      优先权日:2004-06-10
      标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
      发明人:CHOI WOO-BAEG; KOWALIK EWA
      权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
      摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Balatsouras DG, Korres S, Rallis E, Eliopoulos P, Ferekidis E. Twice-daily dosing of loracarbef 15 mg/kg versus 30 mg/kg in the treatment of children with acute sinusitis. Drugs Exp Clin Res. 2005;31 Suppl:1-5. Review.

      合成参考文献


      摘要:S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知